Andrew D. Goldberg

Insider Reports History

Entity
Individual
Location
15440 Laguna Canyon Road, Suite 160, Irvine, CA
Signature
/s/ Scott Sieckert, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew D. Goldberg:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tarsus Pharmaceuticals, Inc. Director Common Stock 6.35K $174K $27.47 Jun 24, 2024 Direct
Tarsus Pharmaceuticals, Inc. Director Stock Option (right to buy) 5K $55K $10.99 Jun 13, 2024 Direct
Tarsus Pharmaceuticals, Inc. Director Restricted Stock Units 0 $0 $27.47 Jun 24, 2024 Direct

Insider Reports Filed by Andrew D. Goldberg

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TARS Tarsus Pharmaceuticals, Inc. Jun 24, 2024 2 $0 4 Jun 25, 2024 Director
TARS Tarsus Pharmaceuticals, Inc. Jun 13, 2024 2 $0 4 Jun 14, 2024 Director
TARS Tarsus Pharmaceuticals, Inc. Dec 15, 2023 1 $19K 4 Dec 19, 2023 Director
TARS Tarsus Pharmaceuticals, Inc. Jun 22, 2023 2 $0 4 Jun 26, 2023 Director
TARS Tarsus Pharmaceuticals, Inc. Jun 16, 2023 2 $0 4 Jun 21, 2023 Director
TARS Tarsus Pharmaceuticals, Inc. Jun 16, 2022 2 $0 4 Jul 1, 2022 Director
TARS Tarsus Pharmaceuticals, Inc. Jun 15, 2021 2 $0 4 Jun 17, 2021 Director